Steve Hoerter

Steve Hoerter currently serves as a member of the Board of Directors for C4 Therapeutics, Inc. and ORIC Pharmaceuticals Inc., as well as previously holding leadership roles including President and CEO at Deciphera Pharmaceuticals and Chief Commercial Officer at Agios Pharmaceuticals and Clovis Oncology. Hoerter has extensive experience in the biotechnology and pharmaceutical sectors, with a background in commercial leadership and strategic management, including positions at Roche, Genentech, and Chiron Corporation. Educational qualifications include a BA from Bucknell University, an MS in Management from Purdue University, and an MBA from Tilburg University.